万维提示：
1、投稿方式：在线投稿。
2、刊内网址（202507期）：
http://www.cell-research.com/
http://www.nature.com/cr（刊内公布但打不开）
3、官网电话：021-54920953；54922841
4、官网邮箱：
cellres@sibcb.ac.cn；leic@sibcb.ac.cn
5、出刊日期：月刊，一年出版12期。
6、官方微信公众号：Cell Research
2026年2月28日星期六
Guidelines - For Author
【官网信息】
Editorial policy
Submission to Cell Research implies that all authors have seen and approved the full manuscript. Corresponding authors of accepted papers will be required to sign a Licence to Publish form on behalf of all authors (see below). To avoid unnecessary delays in the review process, please consider the following policies carefully before submitting your manuscript.
Duplicate publication
Material submitted to the journal must be original and not published or submitted for publication elsewhere in any language. This policy applies to material submitted elsewhere while the contribution to Cell Research is under consideration. Authors submitting a manuscript should notify the editor(s) if part of their contribution has appeared or will appear elsewhere, or if any related material is under consideration or in press elsewhere.
If a submission contains a figure that is published elsewhere or that is copyrighted, the author must provide documentation that the previous publisher or copyright holder has given permission for the figure to be re-published. The editors consider all material in good faith, and assume that the journal has full permission to publish every part of the submitted material, including illustrations.
Conflicts of interest
In the interests of transparency and to help reviewers assess any potential bias, the journal asks authors of research articles to declare any competing commercial interests in relation to the submitted work. Referees are also asked to indicate any potential conflict they might have with reviewing a particular paper.
Electronic manipulation of images
Digital image enhancement is acceptable practice, although it can result in the presentation of unrepresentative data as well as in the loss of meaningful signals. During manipulation of images a positive relationship between the original data and the resulting electronic image must be maintained. If a figure has been subjected to significant electronic manipulation, the specific nature Guidelines for Authors of the enhancements must be noted in the figure legend or in the ‘Materials and methods’ section. The editors reserve the right to request original versions of figures from the authors of a paper under consideration.
Ethical considerations
Protocols for research projects involving human subjects or animals must have been approved by a suitably constituted Ethics Committee of the institution within which the work was undertaken and must conform to the provisions of the Declaration of Helsinki (as revised in Edinburgh 2000). Any experiments involving animals must be demonstrated to be ethically acceptable and, where relevant, conform to national guidelines for animal usage in research.
Supplementary information for editors and reviewers
Any manuscripts under review or accepted for publication elsewhere should accompany the submission if they are relevant to its scientific assessment. Authors should also provide upon submission any kind of supplementary material that will aid the review process.
Format of Papers
Preparation of manuscripts
The manuscript should be double-spaced throughout using 15px Times New Roman/Arial. Number all pages, beginning from title page, and followed by abstract, introduction, results, discussion, materials and methods, acknowledgments, references, figure legends and figures/tables. Gene symbols should be italicized; protein products are not italicized. Non-standard abbreviations should be defined in brackets when first used in the text.
Title page: The title page should include: full title (a brief declarative statement of the major findings of the research), running title (no more than 60 characters including spaces), name of each author, affiliation, city with postal code and corresponding author’s contact information.
Abstract: The abstract should briefly (no more than 250 words) describe in complete sentences the scope of the investigation, the results obtained and the major conclusions. Abbreviations and reference citations should be avoided. 3-7 keywords should be given after the abstract.
Introduction: The introduction should give a brief background knowledge related to the research and should be as concise as possible.
Results: The results should clearly describe the experimental data in tables and figures.
Discussion: The discussion should focus on the interpretation and significance of the findings with concise objective comments.
Materials and Methods: The materials and methods should be described clearly and referenced in sufficient detail.
Acknowledgments: The acknowledgments should be brief and include financial supports along with the numbers of grants.
Gene nomenclature: Authors should use approved nomenclature for gene symbols, and use symbols rather than italicized full names (Ttn, not titin). Please consult the appropriate nomenclature databases for correct gene names and symbols. For proposed gene names that are not already approved, please submit the gene symbols to the appropriate nomenclature committees as soon as possible, as these must be deposited and approved before publication of an article.
References
The references should include only articles that are published or in press. The references are each numbered, ordered sequentially as they appear in the text. List all authors unless there are more than 6, in which case only the first 3 should be given, followed by “et al”.
Please use the following style for references:
Article in a Journal:
1 Zarubin T, Han JH. Activation and signaling of the p38 MAP kinase pathway. Cell Res 2005; 15:11-18. Chapter in a Book:
2 Hirsimaki P, Arstuka AU, Trump BF, Marzella L. Autophagocytosis. In: Trump BF, Arstuka AU, eds. Pathobiology of cell membranes. New York: Plenum Press, 1983:201-236.
A book:
3 Kryger M, Roth T, Dement W, eds. The Principles and Practice of Sleep Medicine. 2nd Edition. Philadelphia: WB Saunders, 1994.
Online Publication:
4 Jelinic P, Stehle JC, Shaw P. The testis-specific factor CTCFL cooperates with the protein methyltransferase PRMT7 in H19 imprinting control region methylation. PLoS Biol 2006; 4: e355.
DOI: 10.1371/journal.pbio.0040355
......
更多详见：
http://www.cell-research.com/Guidelines%20-%20For%20Author.php
